ABCL CIK: 1703057

AbCellera Biologics Inc.

  • Canada
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
245
FY22:
277
FY23:
−43.9
FY24:
−109
FY25:
−131
Change from FY21 to FY25
millions USD
FY21:
−332
FY22:
−353
FY23:
−221
FY24:
121
FY25:
87.8
Change from FY21 to FY25
millions USD
FY21:
−3.89
FY22:
−1.63
FY23:
10.4
FY24:
12.8
FY25:
14.1
millions USD
FY21:
−93.0
FY22:
−86.5
FY23:
−254
FY24:
23.0
FY25:
−28.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
186
FY22:
207
FY23:
−121
FY24:
−187
FY25:
−174

All amounts in millions USD Data source:SEC EDGAR